Recent data reveal delayed pathological kidney changes occurring 8-12 months post-
moderate COVID-19, often detected for the first time. While severe COVID-19 leads to …

Results. Our findings revealed a significant increase in blood and urine levels of TGF-β1 and
VEGF in patients with GN who had a history of moderate COVID-19, compared to those who …

Recently, there have been reports in the scientific-medical literature about the occurrence of
renal pathology after COVID-19 of moderate severity, detected 1 year after this viral …

Abstract Coronavirus disease 2019 (COVID-19) emerged at the end of 2019 and quickly
spread worldwide. Among the various comorbidities associated with severe disease, chronic …

Novel coronavirus 2019 (COVID-19) is a highly infectious disease that causes multiorgan
failure and a high mortality rate. The present study aimed to investigate the association …

Abstract Background and Aims The impact of COVID-19 on the chronic kidney disease
(CKD) has already been confirmed by researchers around the world. However, there is still …

COVID-19, a disease caused by a novel coronavirus (SARS-CoV-2), is a major global threat
that has turned into a pandemic. Despite the emergence of multiple vaccination alternatives …

Background: Patients with chronic diseases such as chronic kidney disease (CKD) have
been reported to have more adverse outcomes during the coronavirus disease 2019 …

Purpose The recent outbreak of COVID-19 rapidly spread worldwide. Comorbid diseases
are determinants of the severity of COVID-19 infection and mortality. The aim of this study …

Purpose COVID-19 frequently affects the kidneys with symptoms ranging from mild
proteinuria to progressive acute kidney injury. This prospective study aimed to assess the …